Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552221080078
Abstract: Background Generally national guidelines for febrile neutropenia recommend treatment with cefepime 2 g every 8 h. Due to beta-lactam’s time dependent killing effects, it is hypothesized smaller doses given more frequently might be non-inferior. The objective of… read more here.
Keywords: time; dose cohort; cefepime; cefepime every ... See more keywords